US OptionsDetailed Quotes
AMED241220P85000
- 0.29
- +0.04+16.00%
15min DelayClose Nov 27 16:00 ET
0.29High0.29Low
0.29Open0.25Pre Close5 Volume3.21K Open Interest85.00Strike Price145.00Turnover25.20%IV7.15%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.29Extrinsic Value100Contract SizeAmericanOptions Type-0.1141Delta0.0340Gamma280.71Leverage Ratio-0.0233Theta-0.0058Rho-32.04Eff Leverage0.0435Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?